All the Drugs Proving Anecdotally Effective Against COVID-19, and the Companies That Make ThemThe Motley Fool • 03/21/20
Why BofA Has Low Expectations For Gilead's Remdesivir As Potential Coronavirus TreatmentBenzinga • 03/20/20
Trump’s Coronavirus News Conference on Thursday: 3 Key Things That Investors Should KnowThe Motley Fool • 03/20/20
Covid Report: Does Gilead Have A Billion-Dollar Drug In Coronavirus?Investors Business Daily • 03/19/20
Drugs or Vaccines: Which Will Be More Crucial Against Coronavirus?Zacks Investment Research • 03/19/20
Big Pharma's Fight Against the Coronavirus Pandemic: Good News and Bad NewsThe Motley Fool • 03/19/20
Analyst Says Gilead's Remdesivir Could Be Approved 'Within Months' For COVID-19 TreatmentBenzinga • 03/19/20
Gilead Sciences - Even Not Counting COVID-19, The Company Has Significant PotentialSeeking Alpha • 03/17/20